China’s CanSino has approval for a clinical trial of a COVID-19 vaccine for inhalation

Via Reuters the news that an inhalable vaccine is to be tested in China.

  • developed by CanSinoBIO and the Beijing Institute of Biotechnology
  • China’s National Medical Products Administration approved the trial of the vaccine

The more vaccines the better I guess?

Source

Leave a Reply

Your email address will not be published. Required fields are marked *